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Figure. 2U1:. Cytotoxicity. of. gemcitabine,. paclitaxel,. ABC294640,. and. PFU543..
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BxPC-3! 1.00! 0.75! 0.82! 0.71! 0.57! 0.49!
MiaPaCa-2! 1.00! 0.78! 0.70! 0.23! 0.06! 0.03!
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(0M50!μM)!resulted!in!a!concentrationMdependent!increases!in!p21!expression!as!
determined!by!immunoblotting!(Figure!3M5a).!!Increasing!p21!is,!therefore,!the!
probable!mechanism!for!hypophosphorylation!of!Rb.!!!
Because!elevation!of!p21!is!associated!with!G1!arrest,!we!examined!the!effect!
of!increasing!concentrations!of!ABC294640!on!the!cell!cycle!distributions!of!the!!
three!pancreatic!cancer!cell!lines.!!We!found!that!increasing!concentrations!of!
ABC294640!result!in!an!increasing!number!of!cells!in!the!G1!phase!for!all!three!cell!
lines,!indicating!a!G1!arrest!(Figure!3M5b).!!
An!increase!in!p21!is!often!the!result!of!increased!p53!activity,!and!all!three!
of!the!cell!lines!under!study!have!inactivating!mutations!in!p53.!!We!examined!the!
impact!of!increasing!concentrations!of!ABC294640!on!total!p53!as!well!as!phosphoM
p53!(S15);!however,!there!were!no!observable!changes!in!either!after!ABC294640!
treatment!(data!not!shown).!!!
!
ABC294640.induces.acetylation.of.lysine.9.on.histone.3.
Recently,!it!was!shown!that!SphK2!overexpression!drives!MYC!
overexpression,!which!inhibits!histone!deacetylases!allowing!for!the!association!of!
H3MK9ac!with!MYC!increasing!its!transcription[261].!!Increasing!lysine!acetylation!
as!a!result!of!inhibition!of!histone!deacetylases!has!also!been!shown!to!increase!p21!
expression[354].!!Our!data!are!consistent!with!both!of!these,!i.e.!inhibition!of!SphK2!
by!ABC294640!results!in!a!concentrationMdependent!increase!in!acetylation!of!
lysine!9!on!histone!3!(Figure!3M5a),!which!corresponds!with!the!increase!in!p21!
expression!and!a!decrease!in!cMMyc.!!Increasing!concentrations!of!ABC294640!
!
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resulted!in!increases!in!acetylation!suggesting!that!inhibition!of!SphK2!results!in!
inhibition!of!histone!deacetylase!activity.!!
!
!Discussion.
Treatment!options!for!nonMresectable!pancreatic!cancer!are!limited!and!
increase!the!average!patient!lifespan!by!only!6M8!months.!!Acquired!resistance!to!
gemcitabine!is!a!major!contributor!to!these!poor!results!indicating!the!need!for!a!
means!to!overcome!this!resistance.!!Here!we!show!that!the!inhibition!of!SphK2!using!
the!selective!inhibitor!ABC294640!synergizes!with!gemcitabine!to!produce!
increased!pancreatic!cancer!cell!killing!in#vitro.!!!Interestingly,!synergy!was!reached!
with!much!lower!concentrations!in!the!most!resistant!cell!line,!MiaPaCaM2,!where!
synergy!was!noted!at!¼!the!gemcitabine!IC50!concentration.!Synergistic!cell!killing!
by!combining!ABC294640!with!gemcitabine!is!in!agreement!with!our!previous!
findings!and!those!of!others!that!ABC294640!can!be!effectively!combined!with!other!
cancer!drugs.!!Herein,!we!support!a!model!in!which!nuclear!S1P!derived!from!SphK2!
contributes!to!chemotherapeutic!resistance!by!potentiating!the!expression!of!proM
proliferative!genes!such!as#MYC!and!RRM2.!!Pharmacologic!inhibition!of!SphK2!leads!
to!a!decrease!in!the!expression!of!these!genes!sensitizing!pancreatic!cancer!cells!to!
gemcitabine.!
The!mechanism!by!which!inhibition!of!SphK2!leads!to!cMMyc!and!RRM2!
suppression!likely!involves!inhibition!of!HDAC!activity,!which!leads!to!a!direct!
increase!in!p21!transcription!and!decrease!in!MYC!transcription.!!The!increase!in!
!
!110!
p21!results!in!a!decrease!in!Rb!phosphorylation!due!to!the!inhibition!of!cyclin/CDK!
complexes.!!Hypophosphorylated!Rb!sequesters!E2F!preventing!its!transcriptional!
activity!resulting!in!a!decrease!in!cMMyc!and!RRM2.!The!data!presented!here!support!
a!role!for!sphingosine!in!the!suppression!of!E2F!mediated!transcription.!!Given!the!
plethora!of!genes!that!E2F!serves!as!a!transcription!factor!for,!attenuation!of!its!
activities!by!the!prohibition!of!its!release!from!Rb!is!an!attractive!target!for!
chemotherapy.!!Additionally,!the!E2F!transcription!factors!are!transcriptional!
targets!of!cMMyc[181].!!Therefore,!Myc!suppression!can!also!indirectly!lead!to!a!
decrease!in!the!transcription!of!E2F!target!gene.!cMMyc!also!acts!as!a!transcriptional!
suppressor!of!p21[172],!and!so!inhibition!of!cMMyc!would!lead!to!a!release!of!p21!
suppression.!!Additionally,!there!is!an!upstream!stimulatory!factor!binding!motif!
within!the!RRM2!promoter!(within!which!there!is!a!nonMcanonical!EMbox!motif)!to!
which!cMMyc!can!bind!and!stimulate!transcription[61].!!In!total,!cMMyc!can!have!a!
transcriptional!impact!on!every!member!of!this!pathway!(Figure!3M6)!creating!a!
redundancy!in!this!system,!ensuring!cell!death.!!!
SphK2!and!SphK2Mderived!S1P!have!been!shown!to!regulate!HDACs[260],!
and!we!postulate!that!inhibition!of!SphK2!by!ABC294640!reduces!the!association!of!
S1P!with!HDAC2!leading!to!a!decrease!in!the!association!of!MYC!with!H3K9ac!and,!
therefore,!decreased!expression[261].!HDAC!inhibitors!are!known!to!cause!an!
induction!of!p21[354].!!As!demonstrated!in!Figure!5,!SphK2!inhibition!by!
ABC294640!inhibited!HDAC!activity.!Therefore,!ABC294640!inhibits!MYC!
transcription!on!two!fronts.!!Not!only!is!the!HDAC!inhibition!directly!decreasing!
MYC!transcription,!but!E2F!mediated!transcription!is!also!effected.!Additionally,!a!!
!
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!
Figure.3U6..Postulated.mechanism.of.action.of.ABC294640..ABC294640!acts!by!
inhibiting!SphK2!in!the!nucleus!leading!to!HDAC!inhibition!because!of!loss!of!
nuclear!S1P!and/or!elevation!of!nuclear!sphingosine!levels.!!This!results!in!an!
increase!in!p21,!which!binds!CDK/CyclinMD1!complexes!preventing!the!
phosphorylation!of!Rb.!!The!resulting!hypophosphorylated!Rb!binds!E2F!preventing!
its!transcriptional!activity.!It!should!also!be!noted!that!cMMyc!inhibits!the!
transcription!of!p21!and!enhances!the!transcription!of!CDKs,!CyclinMD1,!and!E2F1,!2!
and3.!The!overall!result!is!a!decrease!in!proliferative!signaling!thereby!resulting!in!
inhibition!of!cancer!growth..
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third!mechanism!of!ABC294640!mediated!cMMyc!inhibition,!proteosomal!
degradation,!has!been!previously!observed!in!some!cell!lines[290].!!We!report!here!
that!the!proteosome!contributes!to!the!decrease!in!cMMyc!in!some,!but!not!all,!cell!
lines!indicating!that!multiple!potential!mechanisms!for!ABC294640!mediated!cMMyc!
inhibition!are!at!work!in!pancreatic!cancer!cells.!!This!multiMdirectional!mechanism!
of!cMMyc!inhibition,!the!redundancy!of!cell!cycle!arrest!provided!by!cMMyc!inhibition,!
as!well!as!the!inhibition!of!RRM2!transcription!make!ABC294640!ideal!for!
combination!therapy!with!gemcitabine.!!
Herein,!we!show!that!inhibition!of!SphK2!by!ABC294640!results!in!an!
increase!in!p21!that!results!in!G1!arrest.!!This!agrees!with!our!earlier!findings,!which!
showed!that!SphK2!inhibition!via!siRNA!resulted!in!an!increase!in!cells!in!the!G1!
phase!in!A498!cells[332].!The!fate!of!p21!expression!as!a!result!of!SphK2!inhibition!
may!be!cell!type!specific!though.!!Recently!it!was!shown!that!inhibition!of!SphK2!by!
siRNA!led!to!decreased!p21!in!the!MCF7!breast!cancer!cell!line[260].!However,!
exogenous!treatment!of!Hs!27!human!fibroblasts!with!C2Mceramide,!a!substrate!for!
ceramidases!for!the!production!of!sphingosine,!resulted!in!increases!in!p21!and!
growth!arrest[320].!!Inhibition!of!SphK2!with!the!specific!inhibitor!ABC294640!in!
these!three!pancreatic!cell!lines!results!in!a!concentrationMdependent!increase!in!
p21.!!It!is!probable!that!the!differences!in!these!experimental!data!are!due!to!
intrinsic!differences!in!the!cell!types!used.!
Sphingolipid!interaction!with!proteins!has!been!documented!numerous!
times[355,!356].!!Herein,!we!provide!evidence!that!changing!the!nuclear!
sphingolipid!microenvironment!by!inhibition!of!SphK2!diminishes!HDAC!activity!
!
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leading!to!an!increase!in!acetylation!of!lysine!9!on!histone!3!and!a!doseMdependent!
increase!in!p21!expression!and!decrease!in!cMMyc!expression.!SphK2!has!previously!
been!shown!to!directly!interact!with!HDAC[260].!!Our!data!indicate!a!possible!role!
for!an!activity!altering!sphingosine!interaction.!!Additionally,!these!observed!effects!
of!increasing!p21!and!diminished!cMMyc!are!indicative!of!HDAC!inhibition[357,!358].!!
As!well,!HDAC!inhibitors!have!previously!been!used!to!increase!the!efficacy!of!
gemcitabine[359].!!!
The!combination!of!gemcitabine!with!ABC294640!creates!an!environment!
conducive!to!tumor!cell!death.!!Furthermore,!ABC294640!attenuates!multiple!modes!
of!gemcitabine!resistance.!!Antoon!et!al.!demonstrated!the!ability!of!ABC294640!to!
overcome!NFMκB!mediated!chemoresistance!in!breast!cancer[293].!!NFMκB!is!
overexpressed!in!70%!of!pancreatic!cancers[7]!and!a!wellMdocumented!source!of!
gemcitabine!resistance[90].!!Treatment!of!ovarian!cancer!cells!with!ABC294640!
caused!an!increase!in!the!expression!of!BAX[291]!tilting!the!balance!of!the!bclM2!
family!of!proteins,!which!are!known!to!contribute!to!gemcitabine!resistance[138],!in!
the!proMapoptotic!direction.!And!we!show!here!that!ABC294640!reduces!the!
expression!of!cMMyc!and!RRM2.!!Our!combined!data!yield!a!compelling!argument!for!
continued!study!of!these!synergistic!drugs!in!combination.!
As!a!whole,!these!data!contribute!to!our!understanding!of!the!roles!of!SphK2!
in!tumor!biology,!increasing!the!evidence!in!support!of!a!role!for!sphingolipids!as!
regulators!of!gene!transcription.!We!have!also!elucidated!a!mechanism!of!synergy!
with!gemcitabine.!!Few!drugs!counteract!multiple!modes!of!drug!resistance!
!
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rationalizing!the!future!combined!use!of!gemcitabine!and!ABC294640!for!pancreatic!
cancer!chemotherapy.!
!
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Chapter.Four!
Conclusions!and!Future!Directions!
!
!116!
Conclusions.
! !Pancreatic!cancer!is!among!the!most!difficult!cancers!to!treat.!!This!can!be!
attributed!to!two!major!causes!1)!the!delayed!onset!of!symptoms!which!often!
results!in!the!disease!not!being!discovered!until!the!later!stages!and!2)!
chemoresistance!to!the!mainline!chemotherapeutic!gemcitabine.!!This!body!of!work!
explored!circumventing!the!later.!!Resistance!to!gemcitabine!most!often!occurs!
through!aberrations!in!the!enzymes!involved!in!its!metabolism!–!mainly!through!
overexpression!of!the!M2!subunit!of!ribonucleotide!reductase.!!Gemcitabine!
resistance!also!occurs!through!alterations!in!growth!and!apoptotic!signaling!such!
that!growth!is!constitutively!signaled!and!apoptosis!inhibited.!!These!include!
aberrations!in!the!NFMκB!family!and!MAPK!family,!such!that!growth!is!promoted,!
and!disregulation!of!the!BclM2!family!of!proteins,!which!results!in!the!balance!of!antiM
apoptotic!to!proMapoptotic!family!members!shifting!towards!antiMapoptotic.!
Additionally,!over!expression!of!the!protoMoncogene!cMMyc!has!been!shown!to!
promote!resistance!to!gemcitabine.!!!
! The!balance!of!bioactive!sphingolipids!is!also!important!in!determining!cell!
fate.!!An!imbalance,!as!in!an!excess!of!S1P,!promotes!cell!growth.!S1P!has!been!
shown!to!promote!growth!through!NFMκB!and!ERK1/2!signaling.!It!has!also!been!
shown!to!tip!the!balance!of!the!BclM2!family!of!proteins!towards!opposition!of!
apoptosis.!!Additionally,!it!has!been!well!established!that!preventing!the!formation!
of!S1P!by!inhibition!of!SphK2!induces!cell!death.!!Therefore!we!hypothesized!that!
inhibition!of!SphK2!using!the!specific!inhibitor!ABC294640!would!synergize!with!
gemcitabine!to!produce!increased!cell!killing.!!ABC294640!did,!indeed,!synergize!
!
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with!gemcitabine,!however,!the!data!presented!in!Figure!2M3!show!that!ABC294640!
did!not!impact!these!systems!equally!in!three!different!pancreatic!cancer!cell!lines!
suggesting!that!the!mechanism!behind!the!observed!synergy!lied!elsewhere.!
Over!the!past!year,!ABC294640!has!twice!been!reported!to!inhibit!the!
expression!of!cMMyc!through!both!transcriptional!regulation!and!enhanced!
proteosomal!degradation[261,!290].!!Given!that!cMMyc!is!known!to!promote!
resistance!to!gemcitabine!we!examined!the!impact!of!ABC294640!in!three!
pancreatic!cancer!cell!lines!where!we!observed!a!concentrationMdependent!decrease!
in!cMMyc.!!Uncovering!the!connection!between!S1P!and!cMMyc!led!to!the!discovery!
that!ABC294640!caused!a!concentrationMdependent!increase!in!p21,!and!a!
corresponding!decrease!in!Rb!phosphorylation!at!S780.!!Hypophosphorylated!Rb!
binds!E2F!preventing!transcription!of!E2F!target!genes!and,!thereby,!the!
progression!of!the!cell!cycle,!an!effect!we!were!able!observe.!
Overexpression!of!RRM2!has!repeatedly!been!shown!to!confer!resistance!to!
gemcitabine.!!Given!the!nature!of!RRM2’s!function,!nucleotide!production,!it!is!upM
regulated!in!preparation!for!mitosis.!!This!is!facilitated,!in!part,!by!E2F.!!So,!we!
sought!next!to!see!if!ABC294640!impacted!RRM2!transcription,!which!it!did.!!
Therefore,!ABC294640!impacts!the!expression!of!a!potent!oncogene!in!cMMyc!and!
one!of!the!most!commonly!reported!mediators!of!gemcitabine!resistance,!RRM2.!!
The!forced!sequestration!of!E2F!caused!by!ABC294640!allows!for!inhibition!of!both.!!
Our!understanding!of!the!role!of!sphingolipids!in!mediating!resistance!to!
chemotherapeutics!is!growing.!!It!is!know!well!established!that!S1P!has!specific!
nuclear!targets,!HDAC1!and!HDAC2.!!Our!findings!conflict!with!those!showing!that!
!
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S1P!promotes!p21!expression.!!The!data!presented!here!demonstrate!that!the!
inhibition!of!S1P!leads!to!an!increase!in!acetylation!H3K9,!which!promotes!
expression!of!p21.!!ABC,!though!not!likely!directly,!is!promoting!lysine!acetylation!
by!either!inhibiting!HDAC!activity!or!promoting!histone!acetyltransferases!(HAT)!
activity.!!In!agreement!with!my!data,!HDAC!inhibitors!have!previously!been!shown!
to!promote!p21!expression.!!
The!data!presented!here!bolster!the!idea!that!nuclear!S1P!promotes!
proliferation!and!that!inhibition!of!its!production!by!ABC294640!sensitizes!cells!to!
the!cytotoxic!effects!of!gemcitabine!due!to!an!inhibition!of!E2F!mediated!
transcription.!!These!data!also!provide!rationale!supporting!further!preMclinical!
evaluation!of!the!combination!of!ABC294640!and!gemcitabine.!!!
Future.Directions.
! There!is!still!much!to!be!done!in!solidifying!the!mechanism!of!synergy!
between!ABC294640!and!gemcitabine.!!Verifying!that!ABC294640!diminishes!E2F!
mediated!transcription!using!an!E2F!luciferase!reporter!construct!would!strengthen!
the!claim!that!ABC294640!causes!a!decrease!in!E2F!mediated!transcription.!!We!
know!that!ABC294640!specifically!inhibits!SphK2!and!that!SphK2!associates!with!
HDAC1!and!HDAC2.!!However,!specific!competition!studies!showing!that!
ABC294640!prevents!binding!of!S1P!to!HDACs!would!provide!a!linking!proof!
between!ABC294640!and!histone!acetylation.!!We’ve!also!shown!that!ABC294640!
causes!a!dose!dependent!increase!in!p21.!!However,!its!impact!on!cyclins,!cdks!and!
other!cdk!inhibitors!such!as!p15,!p16,!and!p27!is!unknown.!Determining!the!
combinations!of!these!affected!by!ABC294640!would!help!may!unveil!a!specific!role!
!
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for!SphK2!derived!S1P!in!cell!cycle!regulation.!!!It!should!also!be!determined!
whether!suppression!of!p21!through!genetic!ablation!would!abolish!sensitivity!to!
ABC294640.!!
! In!addition!to!unraveling!the!role!of!S1P!in!cell!cycle!progression,!
determining!the!target!genes!of!S1P!mediated!histone!deacetylation!could!establish!
a!therapeutic!profile!of!those!most!likely!to!benefit!from!ABC294640.!!Genetic!
profiling!is!becoming!an!increasingly!more!popular!tool!in!the!clinic.!!As!therapeutic!
decisions!become!more!reliant!on!this!methodology!having!an!understanding!of!S1P!
target!genes!would!allow!for!patient!stratification,!flagging!patients!with!
aberrations!in!S1P!target!genes!as!those!who!may!benefit!most!from!ABC294640.!!!It!
could!also!indicate!potential!future!drug!combination!partners.!
! This!work!also!shows!that!BxPCM3!has!elevated!dhCer!and!dhSph.!!This!cell!
line!was!also!the!most!sensitive!to!gemcitabine.!!Evaluating!the!expression!and!
activity!of!dihydroceramide!desaturase!in!BxPCM3!as!compared!to!MiaPaCaM2!and!
PancM1!may!provide!evidence!supporting!a!role!for!dhCer!and!dhSph!(and!thereby!
dihydroceramide!desaturase)!in!sensitivity!to!gemcitabine.!!Genetic!ablation!of!
dihydroceramide!desaturase!in!MiaPaCaM2!and!PancM1!may!also!support!this!notion.!
This!project!has!elucidated!mechanisms!by!which!ABC294640!enhances!
susceptibility!of!pancreatic!cancer!cells!to!gemcitabine!in!vitro.!An!important!next!
step!will!be!to!validate!this!mechanistic!information!in!preclinical!models.!Current!
mouse!models!fit!into!two!main!categories:!xenografts!and!genetic!models.!!
Xenografts!include!both!subcutaneous!and!orthotopic!xenografts.!!Numerous!
genetically!modified!mouse!models!exist!which!target!tumorgenesis!to!the!pancreas!
!
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by!utilizing!a!pancreas!specific!promoter!element!upstream!of!a!tumor!promoting!
gene!(such!as!mutated!Kras).!!Each!model!possesses!advantages!and!disadvantages.!!
Subcutaneous!xenografts!are!relatively!inexpensive!and!allow!for!the!use!of!human!
pancreatic!cancer!cells.!!However,!the!cells!are!not!in!the!pancreas,!and,!therefore,!
may!respond!differently!to!treatment.!!Orthotopic!xenografts!allow!for!the!growth!of!
human!cancer!cells!in!pancreatic!tissue,!but!are!currently!technically!difficult!to!
produce!reliably!and!growth!is!difficult!to!track.!!Both!xenograft!types!necessitate!
the!use!of!immunocompromised!mice;!therefore,!the!inflammatory!aspect!of!
pancreatic!cancer!is!unaccounted!for!when!evaluating!therapeutics.!!Genetically!
engineered!mice!are!expensive,!however,!they!allow!for!control!over!the!genetic!
impetus!for!tumorgenesis!and!the!mice!are!immunocompetent.!!Tumors!can!take!
several!months!to!develop,!though,!and!tracking!growth!is!difficult[360].!!!
Our!lab!has!developed!a!luciferase!expressing,!orthotopic!pancreatic!cancer!
mouse!model!by!implanting!PancM1!cells!transfected!with!the!pGL4.50[luc2]!plasmid!
into!SCID!mice.!When!provided!with!substrate!the!PancM1Mluc!cells!emit!
luminescence!371!fold!above!background!and!the!light!emitted!is!directly!correlated!
with!the!number!of!cells!present!(Figure!4M1a).!!When!these!cells!were!implanted!
into!the!tails!of!the!pancreases!of!six!SCID!mice,!tumors!were!readily!formed.!!When!
luciferin!was!administered!intraperitoneally!to!the!mice!tumor!growth!could!be!
monitored!using!a!bioluminescence!imager!and!in!this!pilot!study!the!growth!rates!
were!similar!among!all!six!mice!(Figure!4M1b).!!!
While!a!luciferase!expressing!orthotopic!xenograft!model!is!useful,!it!lacks!
the!inflammatory!element!known!to!promote!pancreatic!tumor!growth.!!To!build!on!
!
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!
Figure.4U1:..Development.of.a.luciferase.expressing.orthotopic.mouse.model.
of.pancreatic.cancer.and.caerulein.induced.pancreatitis..(A)!Luciferase!activity!
of!PancM1!and!PancM1!clone!expressing!luciferase!and!the!linearity!of!PancM1Mluc!
luciferase!signal!relative!to!cell!number.!(B)!Tumor!growth!of!orthotopic!tumors!as!
measured!by!bioluminescence!imaging.!(C)!Average!serum!concentrations!of!
amylase!and!lipase!following!treatment!with!either!vehicle!control!or!caerulein!on!
both!the!treatment!day!and!the!day!following!treatment.!(D)!H&E!stain!of!pancreatic!
tissue!samples!from!C57BL/6!mice!treated!with!either!vehicle!control!or!caerulein!
for!10!weeks.!!!
!
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this!model!we!have!transfected!Pan02!cells,!a!pancreatic!cancer!of!C57BL6/J!origin,!
with!the!same!luciferase!gene!as!the!one!introduced!into!the!PancM1Mluc!cells.!!
Implanting!these!Pan02Mluc!cells!into!the!pancreas!of!a!C57BL6/J!mouse!would!
produce!an!orthotopic,!syngeneic!model.!!Such!a!model!would!provide!a!more!
representative!tumor!environment!than!the!orthotopic!xenograft!due!to!the!
presence!of!a!competent!immune!system.!
! Given!both!the!antiMproliferative!and!antiMinflammatory!benefits!of!
ABC294640!and!the!highly!inflammatory!nature!of!pancreatic!cancer,!we!have!also!
begun!work!assessing!the!benefit!of!ABC294640!on!pancreatitis.!Pancreatitis!is!the!
result!of!both!intraMpancreatic!trypsinogen!activation!and!aberrant!NFMκB!activation,!
which!induces!a!local!inflammatory!response.!!These!lead!to!apoptotic!death!of!
acinar!cells!and!a!larger!systemic!inflammatory!response.!!Chronic!pancreatitis!is!
the!result!of!sustained!NFMκB!activation[361].!!Patients!with!chronic!pancreatitis!
have!a!much!higher!risk!of!developing!pancreatic!cancer!when!compared!to!the!
general!population[362].!!The!most!common!mode!of!inducing!chronic!pancreatitis!
in!mice!is!through!repeated!injections!of!the!cholecystokinin!mimetic!caerulein.!!
Caerulein!causes!both!aberrant!activation!of!trypsinogen!and!NFMκB!activation!in!
acinar!cells.!!!
Using!a!biMweekly,!10Mweek,!scheduled!administration!of!caerulein!repeated!
episodes!of!acute!pancreatitis!were!induced!in!C57BL/6!mice!which!led!to!a!chronic!
pancreatitis!phenotype!as!assessed!by!histological!examination.!!!Disease!
progression!was!monitored!through!serum!amylase!and!lipase!levels.!!Blood!
samples!were!obtained!an!hour!after!the!final!dose!of!caerulein!on!the!treatment!
!
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day!and!again!24!hours!later.!!As!expected!serum!amylase!and!lipase!levels!were!
both!elevated!on!the!day!of!treatment,!indicative!of!pancreatitis.!!These!then!
returned!to!near!normal!levels!within!24!hours!(Figure!4M1c).!!Following!the!10M
week!treatment!course,!histological!examination!of!the!pancreases!showed!
disruptions!in!the!organization!of!acini,!ductal!formations,!and!islets!of!Langerhans!
as!well!as!large!areas!of!necrosis!(Figure!4M1d).!!Future!studies!will!utilize!this!
model!to!examine!the!efficacy!of!ABC294640!in!the!treatment!of!pancreatitis.!!Also,!
given!the!high!percentage!of!patients!who!experience!symptoms!of!pancreatitis!and!
pancreatic!cancer!as!coMmorbidities,!we!aim!to!further!our!luciferase!expressing!
orthotopic,!syngeneic!model!by!adding!the!complexities!of!caerulein!induced!
pancreatitis.!!We!believe!this!complicated,!highly!inflammatory!model!will!more!
accurately!reflect!human!disease,!and,!therefore,!be!a!useful!in!preMclinical!drug!
evaluation.!
! This!body!of!work!has!provided!evidence!demonstrating!that!ABC294640!
synergizes!with!gemcitabine!via!suppression!of!E2F!mediated!transcription!through!
increased!acetylation!of!H3K9.!!This!leads!to!inhibition!of!the!expression!of!the!
protoMoncogene!MYC!as!well!as!that!of!gemcitabine!resistance!mediator!RRM2.!!
Moving!forward,!this!evidence!strongly!supports!further!preMclinical!evaluation!of!
the!efficacy!of!the!antineoplastic!combination!of!ABC294640!and!gemcitabine.
!
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